Scientists in Oxford will start to test the world's first vaccine against Bundibugyo Ebola, as an outbreak of the rare virus strain continues to spread across Congo and Uganda.

Scientists from the University of Oxford will begin injecting 50 adults in the UK with Ebola 'within weeks' in a bid to build immunity against the deadly virus.

Oxford University scientists have rapidly created and launched a UK trial of Ebola jab using same technology as its AstraZeneca vaccine against Covid-19

Estudo avaliará segurança e resposta imunológica em 50 adultos saudáveis entre 18 e 55 anos

Oxford begins first human trial of vaccine targeting Bundibugyo Ebola strain

Oxford Vaccine Group initiates the first Phase I trial for Bundibugyo ebolavirus vaccine with support from India's Serum Institute.